Welcome visitor Log In - or - Register
0 items /
View Cart
Check Out
four ways
Quick Search:
MRTX849 (MRTX-849) is an orally available, potent, mutation-selective, and irreversible covalent inhibitor of KRAS-G12C, currently under evaluation as antitumor therapies by modulating KRAS-dependent signal transduction.
Catalog NO: CT-MRTX849
Synonym: MRTX-849
CAS NO: 2326521-71-3
Mol. Formula: C32H35ClFN7O2
MW: 604.1
** in vivo Quality Material. >99% by achiral and chiral HPLCs. Anhydrous, Validated by a spot-on elemental analysis. Bulk Stock!! Prompt